The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGuire Research Institute
• Treatments: Vardenafil Dihydrochloride

Criteria

Inclusion Criteria:

• undergoing cardiac surgery

Exclusion Criteria:

• emergent surgery

• recent MI in past 7 days prior to surgery

• ejection fraction < 35%

• creatinine > 2.0

• prior CVA

• severe COPD

• recent use of nitrates (within past 48 hours prior to surgery)

• prior CABG

• pregnancy